CardioTech to sell biomedical unit

CardioTech International Inc. on Thursday said it will sell its Gish Biomedical Unit after the company posted a narrower third quarter loss.
CardioTech's CEO, Michael Adams, called the biomedical unit a "great bus

Written byLab Manager

| 1 min read

Listen with Speechify

0:00

1:00

CardioTech International Inc. on Thursday said it will sell its Gish Biomedical Unit after the company posted a narrower third quarter loss.

CardioTech's CEO, Michael Adams, called the biomedical unit a "great business," but not in line with the company's strategic direction.

The Lab Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

Gish, makes disposable medical products for various specialties; including cardiovascular surgery, orthopedics and oncology.

Loading Next Article...